| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...877538M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0077538 |
| P932 | PMC publication ID | 3799615 |
| P698 | PubMed publication ID | 24204863 |
| P5875 | ResearchGate publication ID | 258350577 |
| P50 | author | Joanne E McBane | Q59693021 |
| P2093 | author name string | Gregory S Korbutt | |
| Branka Vulesevic | |||
| Erik J Suuronen | |||
| Donna T Padavan | |||
| Kimberly A McEwan | |||
| P2860 | cites work | Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice. | Q50510874 |
| Vascularization of collagen-chitosan scaffolds with circulating progenitor cells as potential site for islet transplantation. | Q53196658 | ||
| A collagen–chitosan hydrogel for endothelial differentiation and angiogenesis. | Q53315869 | ||
| International trial of the Edmonton protocol for islet transplantation. | Q54032399 | ||
| IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. | Q54449054 | ||
| Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. | Q54590204 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes | Q63285820 | ||
| Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-gamma plus tumor necrosis factor-alpha | Q71600908 | ||
| Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization | Q77323614 | ||
| Effect of diabetes mellitus on formation of coronary collateral vessels | Q77393455 | ||
| Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity | Q84070103 | ||
| Tunable collagen hydrogels are modified by the therapeutic agents they are designed to deliver | Q84575725 | ||
| In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation | Q84596161 | ||
| PEG hydrogels formed by thiol-ene photo-click chemistry and their effect on the formation and recovery of insulin-secreting cell spheroids | Q38738805 | ||
| Preparation of glucosamine by hydrolysis of chitosan with commercial α-amylase and glucoamylase | Q38940935 | ||
| Liver natural killer cells play a role in the destruction of islets after intraportal transplantation | Q39578486 | ||
| A novel technique for the transplantation of pancreatic islets within a vascularized device into the greater omentum to achieve insulin independence | Q39737944 | ||
| Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study | Q40569061 | ||
| Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha | Q42031332 | ||
| Islet grafting and imaging in a bioengineered intramuscular space | Q42716769 | ||
| Cytocompatibility studies of mouse pancreatic islets on gelatin--PVP semi IPN scaffolds in vitro: potential implication towards pancreatic tissue engineering | Q42778869 | ||
| Vascularization of artificial beds for pancreatic islet transplantation in a rat model | Q42943630 | ||
| Decreased survival of islet allografts in rats with advanced chronic complications of diabetes | Q44272616 | ||
| Bioartificial pancreas transplantation at prevascularized intermuscular space: effect of angiogenesis induction on islet survival | Q44376878 | ||
| A prevascularized tissue engineering chamber supports growth and function of islets and progenitor cells in diabetic mice | Q44487771 | ||
| Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon | Q45749666 | ||
| Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model | Q46470363 | ||
| Matrix elasticity directs stem cell lineage specification | Q27860761 | ||
| FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16/J mice: preliminary results | Q30454683 | ||
| Evidence of a large-scale mechanosensing mechanism for cellular adaptation to substrate stiffness. | Q30513957 | ||
| Five-year follow-up after clinical islet transplantation | Q33218078 | ||
| Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function | Q34035034 | ||
| Invited review: engineering approaches to cytoskeletal mechanics | Q34071386 | ||
| Controlling the porosity and microarchitecture of hydrogels for tissue engineering | Q34160733 | ||
| Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines | Q34292905 | ||
| Engineered vascular beds provide key signals to pancreatic hormone-producing cells | Q34342360 | ||
| Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine. | Q34472267 | ||
| Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells | Q36402579 | ||
| Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes | Q36411931 | ||
| Endothelial progenitor cells and vascular biology in diabetes mellitus: current knowledge and future perspectives. | Q37065482 | ||
| Optimal implantation site for pancreatic islet transplantation | Q37320025 | ||
| The role of inflammation in insulitis and beta-cell loss in type 1 diabetes | Q37437153 | ||
| Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells | Q37782331 | ||
| Influence of microenvironment on engraftment of transplanted β-cells | Q37834613 | ||
| Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device | Q38453175 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydrogel | Q898925 |
| P304 | page(s) | e77538 | |
| P577 | publication date | 2013-10-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Evaluation of a collagen-chitosan hydrogel for potential use as a pro-angiogenic site for islet transplantation | |
| P478 | volume | 8 |
| Q42228580 | Alginate-Collagen Fibril Composite Hydrogel. |
| Q55428040 | Cardiac differentiation of cardiosphere-derived cells in scaffolds mimicking morphology of the cardiac extracellular matrix. |
| Q35835873 | Development and Characterization of a Collagen-Based Matrix for Vascularization and Cell Delivery |
| Q59128795 | Development of Hydrogel with Anti-Inflammatory Properties Permissive for the Growth of Human Adipose Mesenchymal Stem Cells |
| Q27307789 | Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch |
| Q38741520 | Human hepatocytes loaded in 3D bioprinting generate mini-liver. |
| Q89076737 | In situ type I oligomeric collagen macroencapsulation promotes islet longevity and function in vitro and in vivo |
| Q90471092 | Safety and efficacy of dermal fibroblast conditioned medium (DFCM) fortified collagen hydrogel as acellular 3D skin patch |
| Q55638524 | Therapeutic neovascularization promoted by injectable hydrogels. |
Search more.